1.
|
Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CRAD001C2239, NCT00363051
|
|
2.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 to 90
Sponsor: Pharmaceutical / Industry
Protocol IDs: CRAD001C2240, NCT00410124
|
|
3.
|
Phase: Phase III
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CRAD001C2325, NCT00412061
|
|
4.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: Not specified
Sponsor: Other
Protocol IDs: 2003-0948, NCT00081874
|
|
5.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: MSKCC-04010, NCT00085566
|
|
6.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: RPCI-PH-24204, NOVARTIS-CRAD001C2207, NCT00093639
|
|
7.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MSKCC-04033, NCT00096486
|
|
8.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: UCLA-0409004-01, NOVARTIS-CAEE788A2106, NCT00107237
|
|
9.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 3 to 21
Sponsor: Other
Protocol IDs: RAD001, NCT00187174
|
|
10.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: DUMC-6626-04-12R0, NCT00303732
|
|
11.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 3 and over
Sponsor: Other
Protocol IDs: CCHMC IRB# 06-07-50, NCT00411619
|
|
12.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: Over 18
Sponsor: Other
Protocol IDs: RCC-06-102, 1006-0152, NCT00448149
|
|
13.
|
Phase: Phase II, Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 05-184, NCT00459186
|
|
14.
|
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: VU-VICC-BRE-0523, BRE0523, NCT00574366
|
|
15.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2004-0002, NCT00087685
|
|
16.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-N0377, N0377, NCT00098553
|
|
17.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CRAD001C2222, NCT00107016
|
|
18.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2004-0597, NCT00113360
|
|
19.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CRAD001C2235, NCT00124280
|
|
20.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 16 and over
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: CAN-NCIC-IND163, NOVARTIS-CAN-NCIC-IND163, NCT00255788, IND163
|
|
21.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 100
Sponsor: NCI
Protocol IDs: OHSU-SOL-05108, FWA00000161, OHSU-1754, NCT00331409
|
|
22.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: SCRI GU 32, AVF3673s, NCT00323739
|
|
23.
|
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: CRAD0012467, Swedish Cancer Institute 05128, NCT00337545
|
|
24.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 06-049, NCT00374140
|
|
25.
|
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 06-197, NCT00409292
|
